Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 42385-801

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate (NDC 42385-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ertdf-emt-structure.jpg (Ertdf Emt Structure)

FDA Label Image

Ertdf-figure-1.jpg (Ertdf Figure 1)

This text describes various symptoms that may be associated with a medical condition or illness. These symptoms include fever, skin blisters, mouth sores, redness or swelling of the eyes, swelling of the face, lips, mouth, tongue or throat, trouble breathing or swallowing, pain on the right side of the stomach area, and dark or "tea-colored" urine. These symptoms may indicate the presence of a specific medical issue and require further evaluation or medical attention.*

FDA Label Image

Ertdf-figure-2.jpg (Ertdf Figure 2)

This text lists various symptoms that could indicate a range of health conditions. Some of the symptoms mentioned include diarrhea, nausea, tiredness, headache, dizziness, depression, trouble sleeping, abnormal dreams, and rash. These symptoms may be indicative of different underlying health issues and should be discussed with a healthcare provider for proper evaluation and diagnosis.*

FDA Label Image

Ertdf-figure-3.jpg (Ertdf Figure 3)

Each tablet contains 200 mg of emtricitabine, 27.5 mg of rilpivirine hydrochloride, and 300 mg of tenofovir disoproxil fumarate. This medication is manufactured by Laurus Generics Inc. and should be stored at 20° to 25°C. It is important to keep the container tightly closed and dispense only in the original container. Pharmacists are advised not to cover the ALERT box with a pharmacy label. This product is not to be taken with certain medicines.*

FDA Label Image

Ertdf-ril-structure.jpg (Ertdf Ril Structure)

FDA Label Image

Ertdf-teno-structure.jpg (Ertdf Teno Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.